Akorn, Inc. FDA Inspection Record
Akorn, Inc. is an FDA-inspected facility (FEI 3003102962) located in Gurnee, IL, US. RegDataLab tracks 5 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Mar 5, 2019: No Action Indicated (NAI)
- Inspections on record
- 5 (1 VAI, 4 NAI)
- Last OAI inspection
- None on record
- Warning letters
- 1 listed by FDA for this FEI, latest Oct 2, 2012
- Form 483 and inspection documents
- 1 in FDA's reading room
- Recalls as the recalling firm
- 55, latest Apr 26, 2023
- Import refusals
- 1
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Mar 5, 2019 | No Action Indicated (NAI) | No citations listed |
| Mar 20, 2017 | No Action Indicated (NAI) | No citations listed |
| Feb 13, 2017 | No Action Indicated (NAI) | No citations listed |
| Dec 18, 2015 | No Action Indicated (NAI) | No citations listed |
| Nov 10, 2009 | Voluntary Action Indicated (VAI) | Complaint Handling Procedure (21 CFR 211.198(a)) Complaint Investigation/Follow-Up Findings (21 CFR 211.198(b)(2)) |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Apr 26, 2023 | Class II | D-0779-2023 | Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, packaged… and 85 more products CGMP Deviations: Firm went out of business and could no longer continue stability studies. |
| Jan 30, 2023 | Class III | D-0265-2023 | Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL… Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint. |
| Oct 13, 2022 | Class II | D-0132-2023 | AK-POLY-BAC brand of Bacitracin cand Polymixin B Sulfate Ophthalmic Ointment USP, 3.5 g… and 26 more products CGMP Deviations: |
| Oct 13, 2022 | Class II | V-0034-2023 | Artificial tears, Lubricant ophthalmic ointment, For veterinary use, Net Wt. 3.5 g (1/8… and 6 more products Manufacturing site is closing and subsequently discontinuing stability studies for all marketed products. |
| Sep 21, 2022 | Class II | D-1547-2022 | Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Operating… and 1 more product Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP). |
| Aug 31, 2022 | Class II | D-1495-2022 | Lidocaine Hydrochloride Jelly USP, 2%, Sterile, 30mL tube, Rx only, Manufactured by… and 1 more product cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and… |
| Aug 31, 2022 | Class II | V-0219-2022 | Ofloxacin Ophthalmic Solution, USP 0.3%, Sterile, Rx Only, 5 mL per dropper bottle… Out of specification test results for impurity H (N-Oxide) in 23-month controlled room temperature stability samples. |
| Jun 13, 2022 | Class II | D-1172-2022 | Fluticasone Propionate Nasal Spray, USP, 50 mcg, 16 g net fill weight per amber glass… Defective container: defect prevents product from dispensing as intended. |
| Jun 10, 2022 | Class II | D-1170-2022 | Calcipotriene Topical Solution, 0.005% (Scalp Solution), Rx only, 60 mL (2 fl. oz.)… Defective Delivery System: Potential defect that could prevent the product from dispensing as intended. |
| Apr 15, 2022 | Class III | D-0846-2022 | Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100 mL per bottle, Rx… Failed viscosity specification - product was below specificcation |
Form 483s and inspection documents
FDA record score
38 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
36 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class II recall D-0779-2023, this FEI as the recalling firm | Apr 26, 2023 | 4 x 0.6 | 2.4 |
| Class II recall D-0132-2023, this FEI as the recalling firm | Oct 13, 2022 | 4 x 0.6 | 2.4 |
| Class II recall V-0034-2023, this FEI as the recalling firm | Oct 13, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-1547-2022, this FEI as the recalling firm | Sep 21, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-1495-2022, this FEI as the recalling firm | Aug 31, 2022 | 4 x 0.6 | 2.4 |
| Class II recall V-0219-2022, this FEI as the recalling firm | Aug 31, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-1172-2022, this FEI as the recalling firm | Jun 13, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-1170-2022, this FEI as the recalling firm | Jun 10, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-0460-2022, this FEI as the recalling firm | Jan 5, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-0004-2022, this FEI as the recalling firm | Oct 4, 2021 | 4 x 0.25 | 1 |
| Class II recall D-0717-2022, this FEI as the recalling firm | Sep 8, 2021 | 4 x 0.25 | 1 |
| Class II recall D-0802-2021, this FEI as the recalling firm | Aug 13, 2021 | 4 x 0.25 | 1 |
| Class II recall D-0786-2021, this FEI as the recalling firm | Aug 2, 2021 | 4 x 0.25 | 1 |
| Class II recall D-0301-2021, this FEI as the recalling firm | Mar 8, 2021 | 4 x 0.25 | 1 |
| Class II recall D-0221-2021, this FEI as the recalling firm | Dec 28, 2020 | 4 x 0.25 | 1 |
| Class II recall D-1628-2020, this FEI as the recalling firm | Sep 3, 2020 | 4 x 0.25 | 1 |
| Class II recall D-0647-2020, this FEI as the recalling firm | Nov 15, 2019 | 4 x 0.25 | 1 |
| Class II recall D-1883-2019, this FEI as the recalling firm | Sep 20, 2019 | 4 x 0.25 | 1 |
| Class II recall D-1878-2019, this FEI as the recalling firm | Sep 17, 2019 | 4 x 0.25 | 1 |
| Class II recall D-0993-2019, this FEI as the recalling firm | Feb 22, 2019 | 4 x 0.25 | 1 |
| Class II recall V-0140-2019, this FEI as the recalling firm | Feb 21, 2019 | 4 x 0.25 | 1 |
| Class II recall D-0414-2019, this FEI as the recalling firm | Oct 8, 2018 | 4 x 0.25 | 1 |
| Class II recall D-1183-2018, this FEI as the recalling firm | Aug 24, 2018 | 4 x 0.25 | 1 |
| Class II recall D-1046-2018, this FEI as the recalling firm | Aug 1, 2018 | 4 x 0.25 | 1 |
| Class II recall D-0661-2017, this FEI as the recalling firm | Mar 17, 2017 | 4 x 0.25 | 1 |
| Class II recall D-0949-2016, this FEI as the recalling firm | May 17, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall D-0835-2016, this FEI as the recalling firm | Apr 7, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall D-0874-2016, this FEI as the recalling firm | Mar 23, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1129-2015, this FEI as the recalling firm | Apr 7, 2015 | 10 years or older, so it adds no points | 0 |
| Class II recall D-0995-2015, this FEI as the recalling firm | Mar 17, 2015 | 10 years or older, so it adds no points | 0 |
| Class II recall D-0405-2015, this FEI as the recalling firm | Feb 27, 2015 | 10 years or older, so it adds no points | 0 |
| Class II recall D-0385-2015, this FEI as the recalling firm | Jan 28, 2015 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Oct 2, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Nov 10, 2009 | 10 years or older, so it adds no points | 0 |
| Class II recall D-049-2009, this FEI as the recalling firm | Jul 25, 2008 | 10 years or older, so it adds no points | 0 |
| Class II recall D-081-4, this FEI as the recalling firm | Oct 27, 2003 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Akorn, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Akorn, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Akorn, Inc.
- Location
- Gurnee, IL (US)
- Source
- inspections